Leukocyte-Poor Platelet-Rich Plasma versus Bupivacaine for Recalcitrant Lateral Epicondylar Tendinopathy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Purpose.: To compare a single leukocyte-poor (type-4B) platelet-rich plasma (PRP) injection versus bupivacaine injection for recalcitrant lateral epicondylar tendinopathy (LET). Methods.: 25 patients aged 27 to 50 years with painful and recalcitrant LET of the humerus were randomised to receive leukocyte-poor (type-4B) PRP (n=15) or bupivacaine (n=10) injection. Outcome measures included visual analogue scale (VAS) for pain, modified Mayo clinic performance index for elbow (MMCPIE) for elbow function, and Nirschl score for activity-related pain at 1, 3, 6, and 12 months by a single assessor. Results.: At baseline, the PRP and bupivacaine groups were comparable in terms of age, sex, duration of symptoms, VAS for pain, MMCPIE score, and Nirschl score. After one month, the percentage of improvement was less in the PRP than bupivacaine group in terms of the VAS for pain (17.7% vs. 26.5%), MMCPIE score (24.0% vs. 27.6%), and Nirschl score (20.7% vs. 31.1%). Nonetheless, improvement in the respective scores was greater in the PRP than bupivacaine group after 3 months (42.5% vs. 30.9%, 34.1% vs. 27.2%, and 50.7% vs. 39.6%), 6 months (67.3% vs. 20.1%, 40.6% vs. 16.3%, and 71.4% vs. 31.1%), and one year (83.2% vs. 45.6%, 47.0% vs. 21.7%, and 76.6% vs. 56.3%). The differences in scores between groups were significant at 6 months and one year only (p<0.001). Conclusion.: Leukocyte-poor (type-4) PRP injection for recalcitrant LET enabled good improvement in pain and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thanasas, C., Papadimitriou, G., Charalambidis, C., Paraskevopoulos, I., & Papanikolaou, A. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511417113 · Cited by 351
Cited by
Chahla, J., Cinque, M. E., Piuzzi, N. S., Mannava, S., Geeslin, A. G., Murray, I. R., Dornan, G. J., Muschler, G. F., & LaPrade, R. F. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.01374 · Cited by 504
Current Clinical Recommendations for Use of Platelet-Rich Plasma
Le, A. D. K., Enweze, L., DeBaun, M. R., & Dragoo, J. L. (2018) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-018-9527-7 · Cited by 383
Fitzpatrick, J., Bulsara, M., & Zheng, M. H. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546516643716 · Cited by 340
Chen, X., Jones, I. A., Park, C., & Vangsness, C. T. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517743746 · Cited by 294
Can Platelet rich plasma stimulate human ACL growth in culture? A preliminary experience
Singh Dhillon, M. (2015) · Muscles, Ligaments and Tendons Journal · doi:10.11138/mltj/2015.5.3.156 · Cited by 14
Metadata
- Authors
- Behera, P., Dhillon, M., Aggarwal, S., Marwaha, N., & Prakash, M.
- Venue
- Journal of Orthopaedic Surgery
- Publisher
- SAGE Publications
- Published
- 2015-04
- Volume
- 23
- Issue
- 1
- Pages
- 6-10
- ISSN
- 1022-5536 (ISSN-L)
- 2309-4990
- OpenAlex
- W2101262326
- Cited by
- 83
- References
- 1
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leukocyte-Poor Platelet-Rich Plasma versus Bupivacaine for Recalcitrant Lateral Epicondylar Tendinopathy. https://app.cochat.ai/papers/10.1177/230949901502300102
- The paper
- Behera, P., Dhillon, M., Aggarwal, S., Marwaha, N., & Prakash, M. (2015). Leukocyte-Poor Platelet-Rich Plasma versus Bupivacaine for Recalcitrant Lateral Epicondylar Tendinopathy. Journal of Orthopaedic Surgery. https://doi.org/10.1177/230949901502300102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.